Document is current
Any future updates will be listed below
-
Authors
Ahn, Sung Gwe
Kim, Seon-Kyu
Shepherd, Jonathan H.
Cha, Yoon Jin
Bae, Soong June
Kim, Chungyeul
Jeong, Joon
Perou, Charles M. https://orcid.org/0000-0001-9827-2247
-
Funding
Funding for this research was provided by:
Susan G. Komen
National Research Foundation of Korea (2019R1C1C1002830)
Korea Centers for Disease Control and Prevention (HI14C3396)
the Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 19 January 2021
Accepted: 10 March 2021
First Online: 26 March 2021
Declarations
:
: The following authors or their immediate family members indicated a financial interest. Equity ownership: Charles M Perou, Bioclassifier. Income: Charles M Perou, royalties from PAM50 breast cancer gene patent application; Intellectual Property: Charles M Perou, PAM50 breast cancer gene patent(s). The other authors have no conflict of interest.
: The institutional review board (IRB) of Gangnam Severance Hospital, Yonsei University, Seoul, Korea, approved the study in accordance with good clinical practice guidelines and the Declaration of Helsinki (local IRB Approval Number: 3-2013-0268). The need for informed consent was waived because of the retrospective design.
